News + Press
Texas Biomedical Research Institute scientists have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.
| Read the full story
A monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute prevents infection by the hepatitis C virus (HCV).
| Read the full story
Scientists at Texas Biomed have developed the laboratory opossum as a new animal model to study the most common liver disease in the nation – afflicting up to 15 million Americans – and for which there is no cure.
| Read the full story
The Texas Biomedical Research Institute plans to build a 70,000-square-foot building that will serve as a new front door to the 200-acre campus and allow for the enhancement of existing research programs and the creation of new ones.
| Read the full story
Four of the city's large research institutions announced Wednesday they have formed a partnership to develop new vaccines. All four already have vaccine research under way. The new partnership, called the San Antonio Vaccine Development Center, could have almost $1 million in new funds to spur scientists in new directions, said Kenneth Trevett, president of the Texas Biomedical Research Institute.
| Read the full story
Emergence of resistance to the drug artemisinin in western Thailand has created a critical point in global efforts to control and eliminate malaria worldwide, according to researchers at the Texas Biomedical Research Institute and their collaborators in Thailand. A second study by the same research groups, identifies a major region of the malaria parasite genome associated with artemisinin resistance, raising hope that there will soon be effective molecular markers for monitoring the spread of resistance.
| Read the full story
Two off-the-shelf cancer drugs blocked the deadly Ebola virus from reproducing in the test tube — an early, promising advance in a disease and potential biological weapon with no approved treatments or vaccine, scientists report.
| Read the full story
Texas Biomed scientists have discovered a new animal model which could be effective in research to combat deadly viruses that can be used by bioterrorists and for which there currently are no vaccines.
| Read the full story
Scientists here are rewriting an early chapter of the history books that describes how and when humans first set foot on North American soil, based on clues extracted from the blood of their San Antonio descendants.
| Read the full story
Scientists at the Texas Biomedical Research Institute and Yale University have identified a new target area in the human genome that appears to harbor genes with a major role in the onset of depression.
| Read the full story